Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 9 | 54 | -0,54 % | ||
| KALVISTA PHARMACEUTICALS | 9 | 1 | -2,28 % | ||
| REGENERON PHARMACEUTICALS | 8 | 22 | -0,32 % | ||
| ALNYLAM PHARMACEUTICALS | 6 | 9 | +2,33 % | ||
| PHATHOM PHARMACEUTICALS | 6 | 2 | -8,48 % | ||
 | NOVOCURE | 5 | 11 | +20,80 % | |
| KYMERA THERAPEUTICS | 5 | 6 | -4,27 % | ||
| IONIS PHARMACEUTICALS | 4 | - | +0,22 % | ||
| AC IMMUNE | 4 | - | +8,53 % | ||
| BICYCLE THERAPEUTICS | 3 | 5 | -2,96 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:59 | Orchestra BioMed wins FDA breakthrough nod for pacemaker in hypertension | - | MassDevice | ||
| 16:54 | Alnylam Q1 2026 slides: historic $1B revenue milestone on ATTR-CM surge | 2 | Investing.com | ||
| 16:48 | Novocure jumps after raising FY26 sales outlook, Q1 revenue beat | 1 | Seeking Alpha | ||
| 16:42 | Halozyme Appoints Darren Snellgrove as Chief Financial Officer | 1 | Contract Pharma | ||
| 16:34 | Kymera Therapeutics übertrifft Umsatz- und Gewinnprognosen für Q1 2026 | 1 | Investing.com Deutsch | ||
| 16:27 | Oruka Therapeutics (ORKA) Reports Positive Phase 2a Results for Psoriasis Treatment ORKA-001 | 2 | Insider Monkey | ||
| 16:26 | BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific | 3 | FierceBiotech | ||
| 16:12 | Amneal Pharmaceuticals Q1 2026 Earnings Preview | 1 | Seeking Alpha | ||
| 16:06 | Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA | 240 | AFX News | BASEL (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals in the US and Europe, acquisitions, and a few trial halts, alongside positive data readouts spanning multiple therapeutic... ► Artikel lesen | |
| 15:54 | Phathom Q1 2026 slides: revenue doubles, profitability in sight | 3 | Investing.com | ||
| 15:46 | Indivior Q1 2026: SUBLOCADE treibt EBITDA-Anstieg um 112 % an | 2 | Investing.com Deutsch | ||
| 15:42 | Huahui Health, BeOne Medicines Partner to Advance Oncology Drug HH160 | 1 | Contract Pharma | ||
| 15:30 | Zenas BioPharma rises as CEO continues insider purchases | 1 | Seeking Alpha | ||
| 15:18 | Alnylam Reports Q1 Net Profit As Product Revenue Surges; Stock Up 8% In Pre-Market | 184 | AFX News | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc.(ALNY), an RNAi therapeutics company, on Thursday reported a net income for the first quarter of fiscal 2026, supported by a surge in revenue... ► Artikel lesen | |
| 15:18 | NovoCure Reports Q1 2026 Results: Full Earnings Call Transcript | 1 | Benzinga.com | ||
| 15:18 | Phathom Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 15:10 | KalVista Pharmaceuticals-Aktie: +270% nach sharedealsPlus-Tipp | 264 | sharedeals.de | Die Aktie des US-Biotechunternehmens KalVista Pharmaceuticals ist nach einer zuvor schon starken Performance gestern nochmal einmal um rund +40% explodiert. Grund ist eine milliardenschwere Übernahme:... ► Artikel lesen | |
| 14:34 | Guardant Health und Nuvalent schließen Partnerschaft für Krebsdiagnostik | 1 | Investing.com Deutsch | ||
| 14:30 | Guardant Health partners with Nuvalent on diagnostic tests | 1 | Investing.com | ||
| 14:26 | BeOne signs $2B deal for option on preclinical trispecific antibody from China's Huahui | 2 | FierceBiotech |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.